Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer

By Lin C.-C.   Wu H.-C.   Tsai F.-J.   Chen H.-Y.   Chen W.-C.  

Urology, Vol. 62, Iss. 2, 2003-08 ,pp. : 374-377

Elsevier

Access to resources Recommend Favorite

Gene therapy for prostate cancer

By Shalev M.   Thompson T.C.   Kadmon D.   Ayala G.   Kernen K.   Miles B.J.  

Urology, Vol. 57, Iss. 1, 2001-01 ,pp. : 8-16

Elsevier

Access to resources Recommend Favorite

Lack of association between the HindIII RFLP of the osteocalcin (BGP) gene and bone mineral density (BMD) in healthy pre- and postmenopausal Chinese women

By Mo Xiao-Yang   Cao Chi-Ke   Xu Fu-Hua   Liu Man-Yuan   Li Miao-Xin   Qin Yue-Juan   Zhou Qi   Zhang Yuan-Yuan   Deng Hong-Wen  

Journal of Bone and Mineral Metabolism, Vol. 22, Iss. 3, 2004-05 ,pp. : 264-269

Springer Publishing Company

Access to resources Recommend Favorite

Hormone-refractory Prostate Cancer? Anti-androgen Withdrawal and Intermittent Hormone Therapy

By Sciarra Alessandro   Casale Paolo   Colella Dario   Chiro Costantino Di   Silverio Franco Di  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 4, 1999-09 ,pp. : 211-216

Informa Healthcare

Access to resources Recommend Favorite

Association of Megsin 2093C/T, 2180C/T and C25663G gene polymorphism with the risk of IgA nephropathy

By Mao Song   Ren Xianguo   Huang Songming   Zhang Aihua  

Renal Failure, Vol. 36, Iss. 5, 2014-06 ,pp. : 817-822

Informa Healthcare

Access to resources Recommend Favorite